Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fortress Biotech

1.58
+0.11507.88%
Volume:161.38K
Turnover:243.29K
Market Cap:46.52M
PE:-0.46
High:1.58
Open:1.45
Low:1.45
Close:1.46
Loading ...

This Fortress Biotech Insider Increased Their Holding By 26% Last Year

Simply Wall St.
·
09 Apr

BRIEF-Fortress Biotech Reports 2024 Financial Results And Recent Corporate Highlights

Reuters
·
01 Apr

Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
01 Apr

Fortress Biotech Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Apr

Fortress Biotech FY Revenue USD 55.134 Million

THOMSON REUTERS
·
01 Apr

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

THOMSON REUTERS
·
01 Apr

Press Release: Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

Dow Jones
·
01 Apr

Fortress Biotech’s Mixed Earnings Call: Emrosi’s Launch and Challenges

TIPRANKS
·
29 Mar

Fortress Biotech Inc expected to post a loss of 75 cents a share - Earnings Preview

Reuters
·
29 Mar

Checkpoint Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Mar

Press Release: Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates

Dow Jones
·
28 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Mar

Press Release: Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

Dow Jones
·
27 Mar

Journey Medical Corporation Launches Emrosi™ (40 Mg Minocycline Hydrochloride Modified-Release Capsules, 10 Mg Immediate Release and 30 Mg Extended Release) for the Treatment of Rosacea

THOMSON REUTERS
·
24 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

Fortress Biotech Inc expected to post a loss of 75 cents a share - Earnings Preview

Reuters
·
21 Mar

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

THOMSON REUTERS
·
20 Mar

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

GlobeNewswire
·
20 Mar

Checkpoint Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
18 Mar

Sector Update: Health Care Stocks Gain Monday Afternoon

MT Newswires Live
·
18 Mar